| Geodon Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Geodon 20 mg | powder for injection | intramuscular | 1.0 each | OTC |
| Geodon 80 mg | capsule | oral | 1.0 each | OTC |
| Geodon 20 mg | capsule | oral | 1.0 each | OTC |
| Geodon 40 mg | capsule | oral | 1.0 each | OTC |
| Geodon 60 mg | capsule | oral | 1.0 each | OTC |
Posted by queeenesther 2 days ago
uhhh I just started taking GEODON 2days ago and i've just got the superrr groggy feeling in the morning thru to mid day....i...
Posted by percy44 about 1 month ago
I have been taking Geodon for about 4 months now and it has relieved my bipolar symptoms remarkably well but in the last mont...
Posted by bender 2 months ago
I have been taking Geodon for roughly 2 weeks, and after the 2nd week my dosage was upped to 80mg's. Last night I had to b...
Portsmouth area Senior News - Portsmouth Herald News
Note: At this time future trips will be arranged through GeoDon Tours and Travel. Phone: 772-6071 or (800) 863-5811 to get information or to request ...
Wed Mar 05 06:13:33 -0500 2008
Ambling toward patent cliff, flinty Pfizer boasts of pipeline - Medical Marketing and Media
all 3 news articles
Thu Mar 06 12:31:15 -0500 2008
Portsmouth area Senior News - Portsmouth Herald News
Note: At this time future trips will be arranged through GeoDon Tours and Travel. Phone: 772-6071 or (800) 863-5811 to get information or to request ...
Wed Mar 05 06:13:33 -0500 2008
ziprasidone hydrochloride monohydrate
ziprasidone mesylate - The mesylate salt form of ziprasidone, a benzothiazolylpiperazine derivative and an atypical antipsychotic agent with an antischizophrenic property. Ziprasidone mesylate functions as an antagonist at the dopamine D2 and serotonin 5-HT2A and 5-HT1D receptors, and as an agonist at the 5-HT1A receptor. Ziprasidone mesylate also inhibits the synaptic reuptake of serotonin and norepinephrine. The mechanism of action by which ziprasidone mesylate exerts its antischizophrenic effect is unknown but is potentially mediated through a combination of dopamine D2 and serotonin 5-HT2 antagonism. This agent also has antagonistic activity against histamine H1 and alpha1-adrenergic receptors.